A Review of Parental Vaccine Hesitancy for Human Papillomavirus in Japan
Globally, Japan has the lowest rate of vaccine confidence. The persistent parental vaccine hesitancy has been attributed to safety and efficacy concerns and is primarily driven by the negative experience with human papillomavirus (HPV) vaccines. This literature review aimed to identify factors assoc...
Main Authors: | , , |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-03-01
|
Series: | Journal of Clinical Medicine |
Subjects: | |
Online Access: | https://www.mdpi.com/2077-0383/12/5/2004 |
_version_ | 1797615018928242688 |
---|---|
author | Madoka Lelliott Ethan Sahker Hemant Poudyal |
author_facet | Madoka Lelliott Ethan Sahker Hemant Poudyal |
author_sort | Madoka Lelliott |
collection | DOAJ |
description | Globally, Japan has the lowest rate of vaccine confidence. The persistent parental vaccine hesitancy has been attributed to safety and efficacy concerns and is primarily driven by the negative experience with human papillomavirus (HPV) vaccines. This literature review aimed to identify factors associated with HPV vaccine uptake and potential strategies to reduce vaccine hesitancy among Japanese parents. Articles published in English or Japanese between January 1998 and October 2022 that examined Japanese parental factors for HPV vaccine uptake were identified from PubMed, Web of Science, and Ichushi-Web. In total, 17 articles met the inclusion criteria. Four key themes which affected HPV vaccine hesitancy and acceptance were identified: perceptions of risk and benefits, trust and recommendation, information and knowledge, and sociodemographic characteristics. While governmental and healthcare provider recommendations are important factors, efforts to improve parental confidence in the HPV vaccine are required. Future interventions to counteract HPV vaccine hesitancy should actively disseminate information on vaccine safety and effectiveness, along with information on the severity and susceptibility of HPV infection. |
first_indexed | 2024-03-11T07:20:32Z |
format | Article |
id | doaj.art-5c353fc7356347f8a2aa1abb504ed4e2 |
institution | Directory Open Access Journal |
issn | 2077-0383 |
language | English |
last_indexed | 2024-03-11T07:20:32Z |
publishDate | 2023-03-01 |
publisher | MDPI AG |
record_format | Article |
series | Journal of Clinical Medicine |
spelling | doaj.art-5c353fc7356347f8a2aa1abb504ed4e22023-11-17T08:01:18ZengMDPI AGJournal of Clinical Medicine2077-03832023-03-01125200410.3390/jcm12052004A Review of Parental Vaccine Hesitancy for Human Papillomavirus in JapanMadoka Lelliott0Ethan Sahker1Hemant Poudyal2Department of Health Promotion and Human Behavior, Graduate School of Medicine/School of Public Health, Kyoto University, Kyoto 606-8501, JapanDepartment of Health Promotion and Human Behavior, Graduate School of Medicine/School of Public Health, Kyoto University, Kyoto 606-8501, JapanPopulation Health and Policy Research Unit, Graduate School of Medicine, Kyoto University, Kyoto 606-8501, JapanGlobally, Japan has the lowest rate of vaccine confidence. The persistent parental vaccine hesitancy has been attributed to safety and efficacy concerns and is primarily driven by the negative experience with human papillomavirus (HPV) vaccines. This literature review aimed to identify factors associated with HPV vaccine uptake and potential strategies to reduce vaccine hesitancy among Japanese parents. Articles published in English or Japanese between January 1998 and October 2022 that examined Japanese parental factors for HPV vaccine uptake were identified from PubMed, Web of Science, and Ichushi-Web. In total, 17 articles met the inclusion criteria. Four key themes which affected HPV vaccine hesitancy and acceptance were identified: perceptions of risk and benefits, trust and recommendation, information and knowledge, and sociodemographic characteristics. While governmental and healthcare provider recommendations are important factors, efforts to improve parental confidence in the HPV vaccine are required. Future interventions to counteract HPV vaccine hesitancy should actively disseminate information on vaccine safety and effectiveness, along with information on the severity and susceptibility of HPV infection.https://www.mdpi.com/2077-0383/12/5/2004immunizationchildrenparentscervical cancervirus |
spellingShingle | Madoka Lelliott Ethan Sahker Hemant Poudyal A Review of Parental Vaccine Hesitancy for Human Papillomavirus in Japan Journal of Clinical Medicine immunization children parents cervical cancer virus |
title | A Review of Parental Vaccine Hesitancy for Human Papillomavirus in Japan |
title_full | A Review of Parental Vaccine Hesitancy for Human Papillomavirus in Japan |
title_fullStr | A Review of Parental Vaccine Hesitancy for Human Papillomavirus in Japan |
title_full_unstemmed | A Review of Parental Vaccine Hesitancy for Human Papillomavirus in Japan |
title_short | A Review of Parental Vaccine Hesitancy for Human Papillomavirus in Japan |
title_sort | review of parental vaccine hesitancy for human papillomavirus in japan |
topic | immunization children parents cervical cancer virus |
url | https://www.mdpi.com/2077-0383/12/5/2004 |
work_keys_str_mv | AT madokalelliott areviewofparentalvaccinehesitancyforhumanpapillomavirusinjapan AT ethansahker areviewofparentalvaccinehesitancyforhumanpapillomavirusinjapan AT hemantpoudyal areviewofparentalvaccinehesitancyforhumanpapillomavirusinjapan AT madokalelliott reviewofparentalvaccinehesitancyforhumanpapillomavirusinjapan AT ethansahker reviewofparentalvaccinehesitancyforhumanpapillomavirusinjapan AT hemantpoudyal reviewofparentalvaccinehesitancyforhumanpapillomavirusinjapan |